Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 11:31 p.m.	usa	Adverse reactions/events rate;Seroconversion rate of IgG antibodies against SARS-CoV-2 Phase IIb;Seroconversion rate of Neutralizing antibodies against SARS-CoV-2 Phase IIb;Adverse reactions/events rate	Adverse reactions/events rate;Seroconversion rate of IgG antibodies against SARS-CoV-2 Phase IIb;Seroconversion rate of Neutralizing antibodies against SARS-CoV-2 Phase IIb;Adverse reactions/events rate